Nuvalent, Inc. Operating Income (Loss) in USD from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nuvalent, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2025.
  • Nuvalent, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$113M, a 47.6% decline year-over-year.
  • Nuvalent, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$398M, a 65.6% decline year-over-year.
  • Nuvalent, Inc. annual Operating Income (Loss) for 2024 was -$280M, a 87.5% decline from 2023.
  • Nuvalent, Inc. annual Operating Income (Loss) for 2023 was -$149M, a 73.6% decline from 2022.
  • Nuvalent, Inc. annual Operating Income (Loss) for 2022 was -$86.1M, a 87.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Nuvalent, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$398M -$113M -$36.4M -47.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q2 2025 -$362M -$105M -$39.4M -60.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$323M -$94.8M -$42.2M -80.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$280M -$86.3M -$39.9M -85.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$241M -$76.3M -$37.5M -96.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q2 2024 -$203M -$65.2M -$31.1M -91.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$172M -$52.6M -$22.4M -74.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$149M -$46.4M -$17.1M -58.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$132M -$38.8M -$18.4M -90.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$114M -$34.1M -$15.3M -81.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$98.6M -$30.2M -$12.5M -70.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$86.1M -$29.3M -$11.9M -68.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$74.2M -$20.4M -$7.96M -64.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$66.2M -$18.7M -$8.88M -90.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$57.3M -$17.7M -$11.5M -187% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$45.8M -$17.4M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$12.4M -$8.39M -208% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$9.85M -$5.84M -146% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$6.16M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$4.04M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.01M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-08

Nuvalent, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$280M -$131M -87.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$149M -$63.4M -73.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$86.1M -$40.3M -87.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$45.8M -$28.9M -171% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$16.9M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.